Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
6.80
-0.10 (-1.45%)
At close: Jun 30, 2025, 4:00 PM
6.71
-0.09 (-1.32%)
Pre-market: Jul 1, 2025, 5:46 AM EDT

Tempest Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
2836851236-
Upgrade
Market Cap Growth
-61.32%-57.00%600.22%-66.85%--
Upgrade
Enterprise Value
193295-14-4-
Upgrade
Last Close Price
6.8010.8557.2014.9568.64-
Upgrade
PB Ratio
2.151.903.160.671.01-
Upgrade
P/TBV Ratio
2.501.903.160.671.01-
Upgrade
Debt / Equity Ratio
1.180.800.771.220.510.14
Upgrade
Quick Ratio
1.632.134.174.292.595.84
Upgrade
Current Ratio
1.702.214.294.533.446.15
Upgrade
Return on Equity (ROE)
-282.06%-182.35%-131.42%-131.70%-104.76%-196.78%
Upgrade
Return on Assets (ROA)
-73.47%-56.43%-37.31%-36.29%-35.10%-79.27%
Upgrade
Return on Capital (ROIC)
-86.20%-64.13%-41.58%-45.64%-44.97%-99.17%
Upgrade
Earnings Yield
-161.18%-114.89%-34.82%-295.25%-77.57%-
Upgrade
FCF Yield
-122.84%-91.88%-32.50%-261.55%-71.51%-
Upgrade
Buyback Yield / Dilution
-91.15%-80.99%-33.49%-204.70%-709.63%44.17%
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q